Growth hormone treatment for girls with Turner syndrome
Part of Genetic & congenital, Heart & circulation, Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether a new long-acting growth hormone injection helps girls with Turner syndrome grow taller. Turner syndrome is a genetic condition that affects growth, and this trial will see if this treatment is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Girl aged 2 to under 12 years old, not yet started puberty (Tanner stage I)
- Confirmed Turner syndrome diagnosis from blood test (karyotype analysis)
- Height significantly below normal for age (more than 2 standard deviations below average)
- Bone age delayed or no more than 1 year ahead of actual age
- Never had long-term growth hormone or similar growth-promoting treatment before
- No other growth disorders, serious health conditions, or recent participation in other drug trials
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies the long-term safety and effectiveness of Growtropin®-II, a growth hormone–type injection, in children who are short due to certain causes. It may help your child’s growth over time, while also closely tracking side effects.
This trial tests a weekly growth hormone injection (lonapegsomatropin) compared to the standard daily growth hormone shot in children with short stature due to certain conditions. It aims to see if the weekly shot works as well or better and is safe.
This study compares different hormone treatments to start puberty in girls and women with Turner syndrome who have not yet developed. The goal is to find the safest and most effective way to promote breast development and uterine growth.
This study tests a very low dose of estrogen applied to the skin (like a patch or gel) in girls with Turner syndrome who are just reaching puberty age. The goal is to help with normal growth and development, while avoiding risks of starting too much estrogen too early.
This study follows children who are short for their age and checks how safe and effective growth hormone is over the long term. It may help families understand expected benefits and side effects for their specific growth-related condition.
This study tests a new growth hormone injection (Inpegsomatropin) to help children with idiopathic short stature (short stature with no known cause) grow taller. It may be an option if your child is very short compared to peers and has not started puberty.
Hear when a new Turner Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.